Related Experiment Video
Updated: May 18, 2026
Reprogramming Pancreatic Ductal Adenocarcinoma to Pluripotency
Published on: February 2, 2024
SMAD4-dependent polysome RNA recruitment in human pancreatic cancer cells
Jessica A Thornley1, Heidi W Trask, Carol S Ringelberg
1Norris Cotton Cancer Center, Dartmouth Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.
Abstract:
Pancreatic cancer is the fourth leading cause of cancer death in the United States because most patients are diagnosed too late in the course of the disease to be treated effectively. Thus, there is a pressing need to more clearly understand how gene expression is regulated in cancer cells and to identify new biomarkers and therapeutic targets. Translational regulation is thought to occur primarily through non-SMAD directed signaling pathways. We tested the hypothesis that SMAD4-dependent signaling does play a role in the regulation of mRNA entry into polysomes and that novel candidate genes in pancreatic cancer could be identified using polysome RNA from the human pancreatic cancer cell line BxPC3 with or without a functional SMAD4 gene. We found that (i) differentially expressed whole cell and cytoplasm RNA levels are both poor predictors of polysome RNA levels; (ii) for a majority of RNAs, differential RNA levels are regulated independently in the nucleus, cytoplasm, and polysomes; (iii) for most of the remaining polysome RNA, levels are regulated via a "tagging" of the RNAs in the nucleus for rapid entry into the polysomes; (iv) a SMAD4-dependent pathway appears to indeed play a role in regulating mRNA entry into polysomes; and (v) a gene list derived from differentially expressed polysome RNA in BxPC3 cells generated new candidate genes and cell pathways potentially related to pancreatic cancer.
Insights
This study reveals SMAD4-dependent pathways regulate mRNA translation in pancreatic cancer cells. Identifying these translational changes offers new biomarkers and therapeutic targets for this deadly disease.
Area of Science:
- Molecular Biology
- Cancer Research
- Genetics
Background:
- Pancreatic cancer is a leading cause of cancer death, often diagnosed late.
- Effective treatment requires understanding gene expression regulation and identifying new biomarkers/targets.
- Translational regulation, distinct from transcriptional control, is crucial for gene expression.
Purpose of the Study:
- To investigate the role of SMAD4-dependent signaling in mRNA translation regulation in pancreatic cancer.
- To identify novel candidate genes and pathways in pancreatic cancer through polysome RNA analysis.
- To determine if polysome RNA levels are predictable from whole cell or cytoplasmic RNA levels.
Main Methods:
- Utilized the human pancreatic cancer cell line BxPC3, with and without functional SMAD4.
- Analyzed polysome-bound RNA, whole cell RNA, and cytoplasmic RNA.
- Compared RNA expression levels across different cellular compartments and SMAD4 statuses.
Main Results:
- Differential RNA levels in whole cell and cytoplasm poorly predict polysome RNA levels.
- RNA regulation occurs independently in the nucleus, cytoplasm, and polysomes for most transcripts.
- A SMAD4-dependent pathway influences mRNA entry into polysomes.
- Differential polysome RNA profiling identified novel candidate genes and pathways in pancreatic cancer.
Conclusions:
- SMAD4-dependent signaling plays a significant role in regulating mRNA translation in pancreatic cancer.
- Polysome RNA profiling is a valuable method for discovering novel pancreatic cancer-related genes and pathways.
- Understanding translational control offers new avenues for therapeutic intervention in pancreatic cancer.
